S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Emergent BioSolutions and MorphoSys Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414|
|Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2014|
|U.S. Government Exercises Contract Options Valued at $18.9M for Emergent BioSolutions' Vaccinia Immune Globulin Intravenous Program|
|Emergent BioSolutions Submits Biologics License Application to FDA for Anthrax Immune Globulin Intravenous (Human)|
|Emergent BioSolutions Awarded Contract to Develop a Dry Formulation of NuThrax, a Next Generation Anthrax Vaccine|
|Emergent BioSolutions to Release Second Quarter 2014 Financial Results and Conduct a Conference Call on August 7, 2014|
|MorphoSys and Emergent BioSolutions Sign License Agreement to Co-Develop and Commercialize Prostate Cancer Drug Candidate ES414 (2014/8/19)|
|Amazon Web Services Announces New Lower-Cost, SSD-Backed Option for Amazon Elastic Block Store|
|Wells Fargo Insurance Announces New Regional Leadership for Employee Benefits National Practice|
|L.A. Live Rolls Out Red Carpet For Courtyard And Residence Inn - Hotel Duo Welcomes Influx Of Travelers To Downtown (2014/7/1)|
Click above to view more mutual fund data and stats for ebs - Emergent BioSolutions Inc.